Ukrainian pharmaceutical company Farmak plans to register its products in Malaysia by late 2018, Farmak Business Development Director Oleh Siarkevych has told Interfax-Ukraine.

He said that first the company intends to bring its strategic products to new markets, in particular, insulin and Amizonum created by the company.

In addition, the company plans to offer its ophthalmological portfolio to the Malaysian market, as well as contrast medium.

As reported, as part of the official visit of Poroshenko to Malaysia the Ukrainian-Malaysian Busines Forum was held early August. Ukrainian pharmaceutical manufacturers took part.